Sep 2026
Zidesamtinib in ROS1-positive NSCLC with brain metastases: clinical evidence and therapeutic implications
rearrangements are a unique molecular subset of non-small cell lung cancer (NSCLC),
Abdihakim Sheikh, S. Saleem, S. B. Imran et al.
· Annals of Medicine and Surge... · 0 citations